Schroder Investment Management Group Spring Works Therapeutics, Inc. Transaction History
Schroder Investment Management Group
- $94.5 Billion
- Q3 2024
A detailed history of Schroder Investment Management Group transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 86,895 shares of SWTX stock, worth $3.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,895Holding current value
$3.25 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$210 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$144 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$131 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$128 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.33B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...